Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) · National Institutes of Health
up to $300,000 Due in 39 days

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing ex…

Ask me anything about applying to this grant — your fit, eligibility, or how to start your narrative.

One free message · powered by Grantable AI

Grantable

Welcome to Grantable

Sign in to start building your grant-ready profile

or

We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.